# Boston IVF - CRMI Holding, LLC – FDA Inspection, Jan 9, 2018

Source: https://www.keypedia.com/records/fda_inspections/boston-ivf-crmi-holding-llc/a4968e69-699c-4416-abae-d7e5a435fbd6
Source feed: FDA_Inspections

> FDA inspection 1040885 of Boston IVF - CRMI Holding, LLC, January 09, 2018. Classification: No Action Indicated (NAI). 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1040885
- Company Name: Boston IVF - CRMI Holding, LLC
- Inspection Date: 2018-01-09
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1114964 - 2019-12-19](https://www.keypedia.com/records/fda_inspections/boston-ivf-crmi-holding-llc/2992eeb8-a3c7-485b-bb8e-d70714e6d41d)
- FDA Inspection 857112 - 2013-11-26
- FDA Inspection 764356 - 2012-01-19
- FDA Inspection 625453 - 2009-11-05

## Related Officers

- Issuing Officer

Company: https://www.keypedia.com/companies/boston-ivf-crmi-holding-llc/55714722-3e56-4e8c-80fb-bcb037b6a497

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d